EUV Pellicle Market Size, Share & Growth Forecast (2026-2032)

The EUV Pellicle Market is estimated at USD 0.78 billion in 2026 and is projected to reach USD 1.75 billion by 2032, representing a CAGR of 14.4% during the forecast period.

The economic role of an Extreme ultraviolet (EUV) pellicle is straightforward. It protects an extremely expensive photomask from particle contamination without materially degrading exposure performance. A particle landing directly on the patterned surface can print defects onto wafers. A particle on the pellicle is held sufficiently far from the focal plane that it does not reproduce sharply on the wafer. The technical difficulty is that the protective membrane itself absorbs part of the EUV beam. Pellicle design therefore involves a direct trade-off between protection, optical transmission, thermal durability and mechanical strength. Current low-NA EUV production relies on highly engineered thin membranes that can operate inside ASML scanners while preserving imaging quality. As lithography moves toward higher source power and more aggressive process nodes, pellicle heating becomes more severe. The membrane must dissipate absorbed energy without sagging, rupturing or contaminating the reticle environment. This is pushing the market toward higher-transmittance structures and new material systems. Mitsui Chemicals has commercialized conventional EUV pellicles under license from ASML and is adding CNT products to address the next generation of high-power exposure. Its roadmap places commercial CNT pellicles alongside conventional silicon-based membranes rather than assuming an immediate full replacement. Carbon nanotubes are attractive because a sparse CNT network can combine high EUV transmission with strong thermal stability. However, a laboratory membrane is not automatically a commercial pellicle. Production requires uniform CNT deposition, defect control, stable coating, robust frame attachment, cleanroom manufacturing, particle performance and scanner qualification. The market therefore remains concentrated among a limited number of companies with the ability to qualify both the membrane and the complete pellicle assembly.

Market Drivers

• Higher EUV source power raises the value of low-absorption pellicles. Scanner productivity depends on delivering enough EUV photons to the wafer. When a pellicle absorbs part of the beam, the scanner must compensate through higher source power or longer exposure time. This penalty becomes more visible as semiconductor manufacturers seek higher wafers-per-hour throughput. Mitsui Chemicals has described a roadmap from conventional pellicles toward CNT and next-generation CNT platforms with transmittance above 94%. Its 2026 NEDO-supported program targets at least 95% transmission and durability at 1,000W. The commercial opportunity therefore shifts toward membranes that protect the mask while consuming less of the available photon budget.
• Advanced logic increases recurring pellicle use across more EUV layers. Leading-edge logic processes use EUV across a growing number of critical layers. This increases both the number of masks that may require protection and the operational value of reliable pellicles. Artificial intelligence and high-performance-computing demand is supporting investment in 2nm-class and smaller process technologies. Yield loss from mask contamination is particularly costly in these processes. ASML shipped 48 EUV systems in 2025 and expects EUV revenue to increase significantly in 2026. This expands the installed production base that supports recurring pellicle demand.
• High NA EUV creates a new qualification cycle. High NA EUV increases numerical aperture from 0.33 to 0.55 and introduces new imaging, mask and reticle-handling requirements. Intel Foundry and ASML reported in 2026 that High NA EUV was being used for selected Intel 18A production layers. imec installed an EXE:5200 in Leuven to accelerate ecosystem development. Pellicles for this environment must maintain transmission and dimensional stability under tighter process margins. High NA therefore creates a new qualification cycle even where the basic function of the pellicle remains unchanged.
• Memory manufacturers are evaluating broader pellicle adoption. Memory has historically used EUV differently from leading-edge logic. The number of EUV steps is rising in advanced dynamic random-access memory. Mitsui Chemicals has indicated that memory manufacturers are considering greater use of next-generation CNT pellicles as miniaturization progresses. This can expand demand beyond the foundry and logic customer base. High-value DRAM masks increasingly face the same contamination, throughput and lifetime constraints as logic masks.

Market Restraints

• Qualification remains the largest barrier to rapid supplier expansion. A pellicle must satisfy optical, thermal, particle, outgassing and mechanical requirements simultaneously. It must be accepted within the lithography ecosystem before high-volume use. Higher transmittance alone is not sufficient if a membrane has poor lifetime or unstable coating behavior. The small number of customers operating EUV fabs also concentrates purchasing power and raises the commercial consequences of qualification failure. CNT pellicles face an additional scale-up challenge because CNT synthesis and coating uniformity must remain tightly controlled across a large, extremely thin membrane. Pellicles themselves impose some transmission loss. Fabs can selectively operate pellicle-free on specific masks when contamination risk and handling practices permit. This limits the addressable market for some applications.

Technology and Segment Insights

• Conventional silicon-based pellicles remain the established production platform because they have already passed the demanding scanner and fab qualification process. They are expected to remain important through 2032, particularly on installed 0.33NA systems. CNT pellicles are expected to gain the strongest technology momentum because their high thermal tolerance and higher achievable EUV transmission better fit 600W-plus source-power roadmaps. The transition is likely to be gradual. Next-generation CNT products will enter specific high-value layers and high-power tools first before broader adoption.
• Silicon-based EUV pellicles are established and qualified. Their technical direction is proven mask protection with mature fab qualification. Their primary use case is current 0.33NA EUV production. CNT pellicles are at early commercialization and ramp stage. Their technical direction is higher transmission and improved high-power durability. Their primary use case is 600W-class EUV and advanced-node production. Next-generation coated CNT is at development and qualification stage. Its technical direction targets more than 95% transmission and longer operating life. Its primary use case is High NA and future 1kW-class EUV. Dual-density and reinforced CNT is at development stage. Its technical direction is localized reinforcement for durability without broadly increasing absorption. Its primary use case is high-cycle and demanding exposure environments.
• The market is segmented by pellicle material, lithography platform, semiconductor application, pellicle function and design and geography. Pellicle materials include silicon-based EUV pellicles, carbon nanotube pellicles, coated and reinforced CNT pellicles, and other emerging membrane materials. Lithography platforms include 0.33NA EUV, High NA 0.55NA EUV, and future high-power EUV platforms. Semiconductor applications include leading-edge logic, DRAM and advanced memory, foundry production, and photomask qualification and research and development. Pellicle functions and designs include membrane and optical transmission, frame and mechanical support, coating and surface treatment, complete pellicle assembly, and qualification and lifetime testing.
• Qualified silicon-based pellicles remain the principal commercial platform for current EUV production. Carbon nanotube pellicles move toward commercialization as source power rises beyond 600W. Higher EUV transmittance becomes increasingly valuable because every transmission loss reduces scanner throughput. High NA EUV increases requirements for pellicle flatness, heat resistance and mechanical stability. Asia Pacific leads demand through advanced logic, memory and pellicle manufacturing concentration.

Competitive and Strategic Outlook

• The EUV pellicle market is highly concentrated because successful suppliers must combine advanced membrane materials, cleanroom manufacturing, frame assembly, contamination control and lithography qualification. Mitsui Chemicals has the strongest established commercial position among independent pellicle manufacturers. It commercialized EUV pellicles in 2021 under license from ASML. Its strategy now extends to CNT pellicles, supported by dedicated production capacity, collaboration with imec and a 2026 NEDO-backed high-power development program.
• Canatu participates differently by supplying CNT synthesis technology and manufacturing reactors rather than complete pellicles. Its collaboration with FST provides a scalable path for CNT membrane production and creates a potential second commercial supply chain. FST combines pellicle and semiconductor cleanroom capabilities with the licensed Canatu CNT manufacturing route. LINTEC is developing CNT pellicles and specialized coatings, with emphasis on durability and production readiness. Additional ecosystem participants include S&S Tech, SKC, Shin-Etsu Chemical, Sumitomo Chemical, FUJIFILM and other photomask or contamination-control suppliers that may contribute membrane, frame, coating or related mask-protection technologies.
• Competitive differentiation is increasingly defined by transmission at operating conditions, membrane lifetime, particle adders, thermal deformation, coating stability and qualification speed rather than by nominal material performance alone. Suppliers that can support both current 0.33NA production and future High NA requirements are better positioned to capture the transition without forcing customers to requalify entirely separate supply chains.
• Asia Pacific is the largest commercial market for EUV pellicles because the region combines the highest concentration of leading-edge foundry and memory production with a substantial share of the pellicle and photomask supply chain. Taiwan is central through Taiwan Semiconductor Manufacturing Company, where successive advanced logic nodes increase the number and value of EUV masks in production. South Korea adds demand from Samsung Electronics and SK hynix across advanced logic and DRAM. Korea is also becoming more important on the supply side through companies such as Fine Semitech Corporation. Japan contributes disproportionately through materials, photomask and pellicle manufacturing, including Mitsui Chemicals and LINTEC.
• The region is also where qualification and volume-production feedback cycles are shortest. Pellicle suppliers need direct technical access to fabs, mask shops and lithography ecosystems. Small changes in membrane thickness, coating, particle behavior or frame design can affect scanner performance. Mitsui Chemicals commercialized EUV pellicles in Japan and is expanding into CNT technologies. Its partnership with imec supports qualification against future High NA requirements. FST is scaling CNT membrane production using Canatu reactor technology, providing an additional manufacturing route in South Korea.
• North America is strategically important through Intel, advanced semiconductor research and development and growing leading-edge manufacturing investment in the United States. Intel's 2026 High NA production milestone is particularly important because it provides real production feedback for the next generation of mask and pellicle infrastructure. Europe is essential to the ecosystem through ASML in the Netherlands and imec in Belgium, even though the majority of commercial wafer production remains concentrated in Asia. Europe therefore has an outsized role in pellicle specification, scanner qualification and High NA development relative to its direct pellicle consumption.
• Recent developments confirm accelerating market activity. In August 2026, Canatu received an order from FST for an additional CNT100 SEMI reactor to expand CNT pellicle membrane manufacturing capacity, with delivery expected in 2027. In July 2026, Intel Foundry and ASML reported High NA EUV use on selected Intel 18A production layers, demonstrating production readiness for the next lithography generation. In April 2026, Mitsui Chemicals was selected for a NEDO program targeting pellicles with at least 95% EUV transmission and durability for more than 10,000 wafers at 1,000W source power. In March 2026, Mitsui Chemicals' investment schedule placed its dedicated CNT pellicle facility at 5,000 sheets of annual production capacity. In February 2026, LINTEC announced a durability-enhancing CNT pellicle coating and a dual-density CNT structure aimed at mass-production applications.

Conclusion

• The EUV pellicle market is growing steadily as EUV layer counts and source power increase. Growth is driven by higher EUV source power, growth in EUV layer counts, High NA EUV qualification and memory adoption of EUV pellicles. Silicon-based pellicles remain the principal commercial platform. Carbon nanotube pellicles are moving toward commercialization for 600W-class and future high-power EUV. Asia Pacific leads demand and supply concentration. North America and Europe are strategically important for production feedback and ecosystem development. Long qualification cycles, the transmission versus durability trade-off and the limited qualified supplier base remain the key restraints. The market is projected to grow from USD 0.78 billion in 2026 to USD 1.75 billion by 2032 at a CAGR of 14.4%.

Key Benefits of this Report

• Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
• Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
• Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
• Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
• Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

• Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

• Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2032
• Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
• Competitive positioning, strategies, and market share evaluation, and trade analysis
• Revenue growth and forecast assessment across segments and regions
• Company profiling including strategies, products, financials, and key developments